Core Viewpoint - Beijing Innotech Biotechnology Co., Ltd. has recently obtained a new product qualification, enhancing its market expansion capabilities and core competitiveness [2][3]. Group 1: Recent Qualification - The company has acquired one new product qualification, which is intended for in vitro qualitative detection of Helicobacter pylori antigens in human fecal samples. This product is suitable for both professional medical personnel in medical institutions and for consumer self-testing [2]. Group 2: Impact on the Company - The acquisition of this qualification broadens the range of products offered by the company, thereby improving its market expansion capabilities and core competitiveness [3].